-
Jul 12, 2024 | 00098-x/fulltext&sz=64)
thelancet.com | Mark Weatherall
Hautakangas H Winsvold BS Ruotsalainen SE et al. Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles.
-
Jul 11, 2024 | 
erj.ersjournals.com | Michaela Donaghy |Mark Weatherall |Richard Beasley |Emma Ball
FootnotesThis is a post hoc analysis of a clinical trial prospectively registered at the Australian New Zealand Clinical Trials Registry with identifier number: ACTRN12611000184976. Ethics statement: All the patients provided written informed consent. Conflict of interest: The authors have no potential conflicts of interest to disclose.
-
Jun 20, 2024 | 
erj.ersjournals.com | Richard Beasley |Jonathan Noble |Mark Weatherall
Reply to P.J. McDowell and co-workers:We agree with P.J. McDowell and co-workers that the patients whose data are recorded in the UK Severe Asthma Registry (UKSAR) have, on average, more severe asthma than participants in randomised controlled trials (RCTs) of inhaled corticosteroid (ICS)/formoterol maintenance and reliever therapy (MART) [1, 2].
-
May 16, 2024 | 
erj.ersjournals.com | Mark Weatherall |Richard Beasley |Emma Ball |Michaela Donaghy
FootnotesThis manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article. Conflict of Interest: All authors have nothing to disclose.
-
Mar 28, 2024 | 00091-7/abstract&sz=64)
thelancet.com | Mark Weatherall
The biochemist Hans Krebs (1900–81), who won the Nobel Prize for Physiology or Medicine in 1953, is best known for his discoveries of the processes that underpin energy metabolism in most cells. The citric acid cycle, in particular, with its eponymous designation, is familiar to all doctors who have taken a biochemistry course at medical school. To read this article in full you will need to make a paymentReferences1. Saunders NR Dreifuss JJ Dziegielewska KM et al.
-
Feb 9, 2024 | 00323-x/abstract&sz=64)
thelancet.com | Mark Weatherall
Not even the most egotistical of doctors names a disease after themselves. Such designations are made by others, and eponyms take time to achieve common usage. Neurology abounds with eponymous diseases, such as that named after the 19th century surgeon-apothecary James Parkinson. In his seminal monograph, published in 1817, Parkinson used an old English term for the condition: the shaking palsy.For most of the next 150 years, the disease was known by the Latin equivalent, paralysis agitans.
-
Feb 8, 2024 | 02222-5/abstract&sz=64)
thelancet.com | Thomas Hills |Mark Weatherall |Richard Beasley
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
-
Dec 21, 2023 | 00324-1/abstract&sz=64)
thelancet.com | Mark Weatherall
Mary Walker's pioneering use of physostigmine to treat patients with myasthenia gravis has become justly acclaimed as a turning point in the history of the disease. Dubbed the “miracle at St Alfege's” by the neurologist Henry Viets,Walker presented the case in The Lancet in 1934and expanded upon it in her 1935 MD thesis.
-
Dec 14, 2023 | 
erj.ersjournals.com | Richard Beasley |Jonathan Noble |Mark Weatherall
FootnotesConflict of interest: R. Beasley has received institutional research funding from AstraZeneca, Cure Kids (NZ), Genentech and the Health Research Council of NZ, and personal fees from AstraZeneca, Avillion, Teva Pharmaceuticals and Cipla, outside the submitted work. R. Beasley is chair of the Asthma Foundation of New Zealand adolescent and adult asthma guidelines group. J. Noble and M. Weatherall have no conflicts of interest to declare. Received October 25, 2023. Accepted October 27, 2023.
-
Oct 27, 2023 | 00321-6/abstract&sz=64)
thelancet.com | Mark Weatherall
Death by Lightning. in: Fragments of Science for Unscientific People: a Series of Detached Essays, Lectures, and Reviews. Longmans, Green, and Co, London1871: 421-426
